Examination of validity of a conditioned odor aversion (COA) procedure using low-dose of organic solvent as an applied procedure of the conditioned taste aversion-Reference-Cited by-同舟云学术

Examination of validity of a conditioned odor aversion (COA) procedure using low-dose of organic solvent as an applied procedure of the conditioned taste aversion

Published:2018 Issue:2 Volume:56 Page:141-149
ISSN:0019-8366
Container-title:Industrial Health
language:en
Short-container-title:INDUSTRIAL HEALTH

Author:

HOJO Rieko¹,TAKAYA Mitsutoshi²,YASUDA Akinori¹,TSUCHIYA Masao³,OGAWA Yasutaka⁴

Affiliation:

1. Industrial Toxicology and Health Effects Research Group, Japan Organization of Occupational Health and Safety, National Institute of Occupational Safety and Health, Japan

2. Work Environment Research Group, Japan Organization of Occupational Health and Safety, National Institute of Occupational Safety and Health, Japan

3. Occupational Stress Research Group, Japan Organization of Occupational Health and Safety, National Institute of Occupational Safety and Health, Japan

4. Health Service Facility for the Elderly Hasunehimawarienn, Japan

Publisher

National Institute of Industrial Health

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

https://www.jstage.jst.go.jp/article/indhealth/56/2/56_2017-0041/_pdf

Reference40 articles.

1. 1) Wolkoff P (2013) Indoor air pollutants in office environments: assessment of comfort, health, and performance. Int J Hyg Environ Health 216, 371–94.

2. 2) Wolkoff P, Wilkins CK, Clausen PA, Nielsen GD (2006) Organic compounds in office environments—sensory irritation, odor, measurements and the role of reactive chemistry. Indoor Air 16, 7–19.

3. 3) Seiren Inc J (2014) Deoest [in Japanese; online 14 April 2014].

4. 4) AEAJ News release (2013) Research report about aroma market. AEAJ (Aroma Environment Association of Japan).

5. 5) Caress SM, Steinemann AC (2009) Prevalence of fragrance sensitivity in the American population. J Environ Health 71, 46–50.